2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial von Goldhirsch, Aron, Prof, Gelber, Richard D, Prof, Piccart-Gebhart, Martine J, Prof, de Azambuja, Evandro, MD, Procter, Marion, MSci, Suter, Thomas M, Prof, Jackisch, Christian, Prof, Cameron, David, Prof, Weber, Harald A, MD, Heinzmann, Dominik, PhD, Lago, Lissandra Dal, MD, McFadden, Eleanor, MA, Dowsett, Mitch, Prof, Untch, Michael, Prof, Gianni, Luca, MD, Bell, Richard, Prof, Köhne, Claus-Henning, Prof, Vindevoghel, Anita, MD, Andersson, Michael, MD, Brunt, A Murray, MD, Otero-Reyes, Douglas, MD, Song, Santai, MD, Smith, Ian, Prof, Leyland-Jones, Brian, PhD, Baselga, Jose, Prof

Volltext

Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2... von Wildiers, Hans, Meyskens, Thomas, Marréaud, Sandrine, Lago, Lissandra Dal, Vuylsteke, Peter, Curigliano, Giuseppe, Waters, Simon, Brouwers, Barbara, Meulemans, Bart, Sousa, Berta, Poncet, Coralie, Brain, Etienne

Volltext

Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) von Pondé, Noam, Agbor-Tarh, Dominique, Dal Lago, Lissandra, Korde, Larissa A., Hilbers, Florentine, Jackisch, Christian, Werner, Olena, Gelber, Richard D., Jatoi, Aminah, Dueck, Amylou C., Moreno-Aspitia, Alvaro, Sotiriou, Christos, de Azambuja, Evandro, Piccart, Martine

Volltext

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial von Bonnefoi, Hervé, Prof, Piccart, Martine, Prof, Bogaerts, Jan, PhD, Mauriac, Louis, MD, Fumoleau, Pierre, Prof, Brain, Etienne, MD, Petit, Thierry, Prof, Rouanet, Philippe, Prof, Jassem, Jacek, Prof, Blot, Emmanuel, MD, Zaman, Khalil, MD, Cufer, Tanja, Prof, Lortholary, Alain, MD, Lidbrink, Elisabet, MD, André, Sylvie, Litière, Saskia, PhD, Lago, Lissandra Dal, MD, Becette, Véronique, MD, Cameron, David A, Prof, Bergh, Jonas, Prof, Iggo, Richard, Prof

Volltext

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer von Ignatiadis, Michail, Zardavas, Dimitrios, Lemort, Marc, Wilke, Celine, Vanderbeeken, Marie-Catherine, D'Hondt, Veronique, De Azambuja, Evandro, Gombos, Andrea, Lebrun, Fabienne, Dal Lago, Lissandra, Bustin, Fanny, Maetens, Marion, Ameye, Lieveke, Veys, Isabelle, Michiels, Stefan, Paesmans, Marianne, Larsimont, Denis, Sotiriou, Christos, Nogaret, Jean-Marie, Piccart, Martine, Awada, Ahmad

Volltext

Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad? von Gombos, Andrea, Metzger-Filho, Otto, Dal Lago, Lissandra, Awada-Hussein, Ahmad

Volltext

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, ph... von Wildiers, Hans, Tryfonidis, Konstantinos, Dal Lago, Lissandra, Vuylsteke, Peter, Curigliano, Giuseppe, Waters, Simon, Brouwers, Barbara, Altintas, Sevilay, Touati, Nathan, Cardoso, Fatima, Brain, Etienne

Volltext

Rare Features of Dermatomyositis in a Patient with Ovarian Cancer von Dal Lago, Lissandra, Vandergheynst, Frédéric, Awada, Ahmad, Pepersack, Thierry

Volltext

Sarcoidosis Versus Lymphoma? von Dal Lago, Lissandra, Sarrand, Julie, Woff, Erwin, Awada, Ahmad, Vouche, Michaël, Pepersack, Thierry

Volltext

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymp... von Aapro, M.S, Bohlius, J, Cameron, D.A, Lago, Lissandra Dal, Donnelly, J. Peter, Kearney, N, Lyman, G.H, Pettengell, R, Tjan-Heijnen, V.C, Walewski, J, Weber, Damien C, Zielinski, C

Volltext

Evaluation of multiple transcriptomic gene risk signatures in male breast cancer von Bayani, Jane, Poncet, Coralie, Crozier, Cheryl, Neven, Anouk, Piper, Tammy, Cunningham, Carrie, Sobol, Monika, Aebi, Stefan, Benstead, Kim, Bogler, Oliver, Dal Lago, Lissandra, Fraser, Judith, Hilbers, Florentine, Hedenfalk, Ingrid, Korde, Larissa, Linderholm, Barbro, Martens, John, Middleton, Lavinia, Murray, Melissa, Kelly, Catherine, Nilsson, Cecilia, Nowaczyk, Monika, Peeters, Stephanie, Peric, Aleksandra, Porter, Peggy, Schröder, Carolien, Rubio, Isabel T., Ruddy, Kathryn J., van Asperen, Christi, Van Den Weyngaert, Danielle, van Deurzen, Carolien, van Leeuwen-Stok, Elise, Vermeij, Joanna, Winer, Eric, Giordano, Sharon H., Cardoso, Fatima, Bartlett, John M. S.

Volltext

Evaluation of the Comprehensive Geriatric Assessment (CGA) tool as a predictor of postoperative complications following major oncological abdominal surgery in geriatric patients von Penning, Yoon, El Asmar, Antoine, Moreau, Michel, Raspé, Julie, Dal Lago, Lissandra, Pepersack, Thierry, Donckier, Vincent, Liberale, Gabriel

Volltext

The efficacy of the American College of Surgeons Surgical Risk Calculator in the prediction of postoperative complications in oncogeriatric patients after curative surgery for abdo... von El Asmar, Antoine, Hafez, Karim, Fauconnier, Pauline, Moreau, Michel, Dal Lago, Lissandra, Pepersack, Thierry, Donckier, Vincent, Liberale, Gabriel

Volltext

HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology von Brain, Etienne, Caillet, Philippe, de Glas, Nienke, Biganzoli, Laura, Cheng, Karis, Lago, Lissandra Dal, Wildiers, Hans

Volltext

Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity von Berretta, Massimiliano, Dal Lago, Lissandra, Tinazzi, Mattia, Ronchi, Andrea, La Rocca, Gaspare, Montella, Liliana, Di Francia, Raffaele, Facchini, Bianca Arianna, Bignucolo, Alessia, Montopoli, Monica

Volltext

Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study von Simon, Sergio Daniel, Bines, José, Werutsky, Gustavo, Nunes, João Soares, Pacheco, Fernando Chalu, Segalla, José Getúlio, Gomes, Andrea J.S., Adam Van Eyll, Brigitte Marie H.R., Gimenes, Daniel Luiz, Crocamo, Susanne, Freitas-Junior, Ruffo, Lago, Lissandra Dal, Queiroz, Geraldo Silva, Jobim de Azevedo, Sérgio, Rosa, Daniela Dornelles, Delgado, Gilson, Borges, Giuliano Santos, Verônica do Nascimento, Yeni, Zaffaroni, Facundo, Martínez-Mesa, Jeovany, Barrios, Carlos H.E.

Volltext

Information perception, wishes, and satisfaction in ambulatory cancer patients under active treatment: patient-reported outcomes with QLQ-INFO25 von Pinto, Ana Catarina, Ferreira-Santos, Fernando, Lago, Lissandra Dal, de Azambuja, Evandro, Pimentel, Francisco Luís, Piccart-Gebhart, Martine, Razavi, Darius

Volltext

Use of information and communication technologies (ICTs) in cancer multidisciplinary team meetings: an explorative study based on EU healthcare professionals von Prades, Joan, Coll-Ortega, Cristina, Dal Lago, Lissandra, Goffin, Karolien, Javor, Eugen, Lombardo, Claudio, de Munter, Johan, Ponce, Jordi, Regge, Daniele, Salazar, Ramón, Valentini, Vincenzo, Borras, Josep M

Volltext

Targeted therapy for breast cancer in older patients von Pondé, Noam, Wildiers, Hans, Awada, Ahmad, de Azambuja, Evandro, Deliens, Coralie, Lago, Lissandra Dal

Volltext

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D) von Pondé, Noam, Agbor‑Tarh, Dominique, Dal Lago, Lissandra, Korde, Larissa A., Hilbers, Florentine, Jackisch, Christian, Werner, Olena, Gelber, Richard D., Jatoi, Aminah, Dueck, Amylou C., Moreno‑Aspitia, Alvaro, Sotiriou, Christos, de Azambuja, Evandro, Piccart, Martine

Volltext